<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20031101//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3033911</article-id><article-id pub-id-type="pmid">21326867</article-id><article-id pub-id-type="publisher-id">PONE-D-10-04853</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0016894</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Molecular Cell Biology</subject><subj-group><subject>Cellular Stress Responses</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Hematology</subject><subj-group><subject>Anemia</subject><subject>Hematopoiesis</subject><subject>Red Cells</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="6474" pm="."><plain>SOD2 Deficient Erythroid Cells Up-Regulate Transferrin Receptor and Down-Regulate Mitochondrial Biogenesis and Metabolism </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Gene Expression Changes in SOD2-/- Erythroblasts</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Martin</surname><given-names>Florent M.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Xiuling</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>von Löhneysen</surname><given-names>Katharina</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gilmartin</surname><given-names>Timothy J.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Friedman</surname><given-names>Jeffrey S.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, United States of America</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>DNA Array Core Facility, The Scripps Research Institute, La Jolla, California, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Means</surname><given-names>Robert</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Yale Medical School, United States of America</aff><author-notes><corresp id="cor1">* E-mail: <email>friedman@scripps.edu</email></corresp><fn fn-type="con"><p><text><SENT sid="6475" pm="."><plain>Conceived and designed the experiments: JSF FMM. </plain></SENT>
<SENT sid="6476" pm="."><plain>Performed the experiments: JSF FMM XX. </plain></SENT>
<SENT sid="6477" pm="."><plain>Analyzed the data: JSF FMM TG XX KvL. </plain></SENT>
<SENT sid="6478" pm="."><plain>Contributed reagents/materials/analysis tools: TG. </plain></SENT>
<SENT sid="6479" pm="."><plain>Wrote the paper: JSF FMM. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>4</day><month>2</month><year>2011</year></pub-date><volume>6</volume><issue>2</issue><elocation-id>e16894</elocation-id><history><date date-type="received"><day>9</day><month>11</month><year>2010</year></date><date date-type="accepted"><day>5</day><month>1</month><year>2011</year></date></history><permissions><copyright-statement>Martin et al.</copyright-statement><copyright-year>2011</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title><text><SENT sid="6480" pm="."><plain>Background </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="6481" pm="."><plain>Mice irradiated and reconstituted with hematopoietic cells lacking manganese superoxide dismutase (SOD2) show a persistent hemolytic anemia similar to human sideroblastic anemia (SA), including characteristic intra-mitochondrial iron deposition. </plain></SENT>
<SENT sid="6482" pm="."><plain>SA is primarily an acquired, clonal marrow disorder occurring in individuals over 60 years of age with uncertain etiology. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="6483" pm="."><plain>Methodology/Principal Findings </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="6484" pm="."><plain>To define early events in the pathogenesis of this murine model of SA, we compared erythroid differentiation of Sod2-/- and normal bone marrow cells using flow cytometry and gene expression profiling of erythroblasts. </plain></SENT>
<SENT sid="6485" pm="."><plain>The predominant transcriptional differences observed include widespread down-regulation of mitochondrial metabolic pathways and mitochondrial biogenesis. </plain></SENT>
<SENT sid="6486" pm="."><plain>Multiple nuclear encoded subunits of complexes I-IV of the electron transport chain, ATP synthase (complex V), TCA cycle and mitochondrial ribosomal proteins were coordinately down-regulated in Sod2-/- erythroblasts. </plain></SENT>
<SENT sid="6487" pm="."><plain>Despite iron accumulation within mitochondria, we found increased expression of transferrin receptor, Tfrc, at both the transcript and protein level in SOD2 deficient cells, suggesting deregulation of iron delivery. </plain></SENT>
<SENT sid="6488" pm="."><plain>Interestingly, there was decreased expression of ABCb7, the gene responsible for X-linked hereditary SA with ataxia, a component required for iron-sulfur cluster biogenesis. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="6489" pm="."><plain>Conclusions/Significance </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="6490" pm="."><plain>These results indicate that in erythroblasts, mitochondrial oxidative stress reduces expression of multiple nuclear genes encoding components of the respiratory chain, TCA cycle and mitochondrial protein synthesis. </plain></SENT>
<SENT sid="6491" pm="."><plain>An additional target of particular relevance for SA is iron:sulfur cluster biosynthesis. </plain></SENT>
<SENT sid="6492" pm="."><plain>By decreasing transcription of components of cluster synthesis machinery, both iron utilization and regulation of iron uptake are impacted, contributing to the sideroblastic phenotype. </plain></SENT>
</text></SecTag></p></sec></abstract><counts><page-count count="12"/></counts></article-meta></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="6493" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="6494" pm="."><plain>Reconstitution of mice with hematopoietic stem cells deficient in manganese superoxide dismutase (SOD2) results in a hemolytic anemia that recapitulates many features seen in patients with sideroblastic anemia (SA) [1]. </plain></SENT>
<SENT sid="6495" pm="."><plain>SA's are a heterogeneous group of inherited and acquired erythropoietic disorders with defining features being the presence of bone marrow ringed sideroblasts (RS), abnormal erythroblasts with pathologic mitochondrial iron deposition, and impaired heme biosynthesis [2], [3], [4], [5]. </plain></SENT>
</text></p><p><text><SENT sid="6496" pm="."><plain>The molecular genetic basis for several of the inherited forms of SA has been described. </plain></SENT>
<SENT sid="6497" pm="."><plain>There are two X-linked sideroblastic anemias (XLSAs), one caused by mutations of an erythroid-specific form of the heme biosynthetic enzyme aminolevulinic acid-synthase (ALAS2) [6], and one caused by mutation of a mitochondria-localized transport protein, ATP-binding cassette, member b7 (ABCb7) [7]—that plays a role in maturation/transport of iron-sulfur cluster containing proteins. </plain></SENT>
<SENT sid="6498" pm="."><plain>Mutation of the pseudouridylate synthase 1 gene (PUS1) was found to cause mitochondrial myopathy and SA [8], [9]. </plain></SENT>
<SENT sid="6499" pm="."><plain>How this lesion specifically affects mitochondrial function or iron metabolism is unclear—but it has been proposed that pseudouridylation of small RNA's distinct from tRNA may affect mitochondrial function [10]. </plain></SENT>
<SENT sid="6500" pm="."><plain>Another type of SA presenting in infancy or childhood, Pearson marrow–pancreas syndrome, results from a large deletion in mitochondrial DNA (mtDNA) [11] and evolves features similar to the multi-system mitochondrial disorder Kearn-Sayers syndrome. </plain></SENT>
<SENT sid="6501" pm="."><plain>A single patient has been reported with a splice site mutation in the glutaredoxin 5 gene (GLRX5) as a cause of SA [12]. </plain></SENT>
<SENT sid="6502" pm="."><plain>Most recently, mutations in a mitochondrial carrier family gene (SLC25A38) have been identified in cases of hereditary SA [13]. </plain></SENT>
<SENT sid="6503" pm="."><plain>Analysis of SLC25A38 in a larger collection of hereditary SA samples confirmed that this gene is involved in a significant fraction (∼15%) of hereditary SA cases, although a large number of cases remain genetically undefined (&gt;40%) [14]. </plain></SENT>
</text></p><p><text><SENT sid="6504" pm="."><plain>The majority of cases of SA are acquired, occur in the context of the bone marrow failure syndrome myelodysplasia (MDS) and remain idiopathic. </plain></SENT>
<SENT sid="6505" pm="."><plain>In the small number of acquired SA cases where a defined genetic lesion has been identified, mitochondria are also implicated in pathogenesis. </plain></SENT>
<SENT sid="6506" pm="."><plain>Somatic point mutations of mtDNA encoding subunit 1 of cytochrome c oxidase (COX1; i.e., complex IV of the respiratory chain) have been found in patients with acquired idiopathic sideroblastic anemia (AISA) resulting in measurable respiratory chain dysfunction [15]. </plain></SENT>
<SENT sid="6507" pm="."><plain>There are reports of mutations affecting other portions of the mtDNA including cytochrome b or mitochondrial encoded tRNAs in isolated cases of SA [16], [17], [18], [19]. </plain></SENT>
<SENT sid="6508" pm="."><plain>However, there remains considerable uncertainty as to the role of acquired mtDNA mutations in SA and more broadly in the pathogenesis of MDS [20]. </plain></SENT>
</text></p><p><text><SENT sid="6509" pm="."><plain>Some cases of acquired, reversible SA have been associated with specific drugs; the antibiotic chloramphenicol exerts its toxicity via inhibition of mitochondrial protein synthesis, suppressing the bone marrow, and can induce SA [21]; anti-tuberculosis therapy interferes with pyridoxine metabolism, a cofactor for ALAS2, and can result in SA [22], [23]. </plain></SENT>
<SENT sid="6510" pm="."><plain>Thus, both genetics and drug toxicity data indicate that mitochondrial dysfunction plays a key role in the etiology of SA. </plain></SENT>
<SENT sid="6511" pm="."><plain>While specific mechanisms responsible for iron overload in developing red cells remain poorly understood, mitochondrial dysfunction (due to a diverse array of genetic lesions or toxic exposures) appears to be both necessary and sufficient to create a convergent phenotype of pathologic intra-mitochondrial iron deposition that is characteristic of SA. </plain></SENT>
</text></p><p><text><SENT sid="6512" pm="."><plain>SOD2 is a mitochondrial antioxidant enzyme that detoxifies superoxide anion radicals (O2 .-), a byproduct of mitochondrial respiration. </plain></SENT>
<SENT sid="6513" pm="."><plain>SOD2-deficiency induces severe mitochondrial dysfunction in neurons and muscle leading to embryonic or neonatal lethality in homozygous mutant mice [24]. </plain></SENT>
<SENT sid="6514" pm="."><plain>To analyze the impact of SOD2-deficiency in hematopoietic tissues over long periods of time, we have used fetal liver cells as a source of hematopoietic stem cells (HSC) to reconstitute lethally irradiated mice [1]. </plain></SENT>
<SENT sid="6515" pm="."><plain>Sod2-/- HSC rescue irradiated wild-type recipients, however, Sod2-/- chimeric mice have a persistent hemolytic anemia. </plain></SENT>
<SENT sid="6516" pm="."><plain>Sod2-/- red blood cells (RBC) show increased oxidative damage and have a shortened lifespan [1]. </plain></SENT>
<SENT sid="6517" pm="."><plain>Siderocytes (iron-loaded reticulocytes found in marrow or peripheral blood of Sod2-/- chimeric animals) produced enhanced levels of reactive oxygen species (ROS) and showed increased protein oxidative damage, increased mitochondrial number and mass as well as mitochondrial hyperpolarization [25], [26]. </plain></SENT>
<SENT sid="6518" pm="."><plain>These results suggest that intramitochondrial oxidative stress is an important element in the pathogenesis of SA, and is sufficient to induce pathologic iron accumulation in mitochondria of developing RBC [27]. </plain></SENT>
<SENT sid="6519" pm="."><plain>Characterization of sideroblasts isolated from the marrows of patients with acquired or hereditary SA also showed increased ROS production, oxidative damage to protein and mitochondrial hyperpolarization—indicating that these features are shared between the murine SOD2 model and clinical samples [28]. </plain></SENT>
<SENT sid="6520" pm="."><plain>In order to better characterize this unique sideroblastic-like phenotype and to identify putative targets of oxidative stress that may be important regulators of red cell development or iron homeostasis, we compared erythroid development and gene expression patterns between normal and Sod2-/- erythroid progenitors. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS"><sec id="s2"><title><text><SENT sid="6521" pm="."><plain>Results </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="6522" pm="."><plain>Sod2-/- erythropoiesis shows a maturational left shift </plain></SENT>
</text></title><p><text><SENT sid="6523" pm="."><plain>We used a FACS-based method tracking expression of the erythroid-specific antigen TER-119 and CD71 (transferrin receptor) [29], [30] to compare normal and Sod2-/- erythroid differentiation (figure 1A) in murine bone marrow. </plain></SENT>
<SENT sid="6524" pm="."><plain>Taken as a whole, the CD71Lo-Hi TER-119Hi population encompassing the early basophilic erythroblast to reticulocyte stages (gates R4-R6, figure 1A) was increased in Sod2-/- marrows. </plain></SENT>
<SENT sid="6525" pm="."><plain>In particular, CD71Hi TER-119Hi Sod2-/- basophilic erythroblasts (R4) were increased relative to normal (1.9-fold), and Sod2-/- CD71- TER-119Hi reticulocytes and mature RBC (R7) were decreased relative (5.9-fold) to normal (bar graph, figure 1B). </plain></SENT>
<SENT sid="6526" pm="."><plain>Sod2-/- marrow showed a mild erythroid hyperplasia with a 1.6-fold increase in numbers of total erythroblasts (Gate R4 in figure 1C: FSCMed-Hi PI- TER-119+ CD71+ cells) compared to normal marrow, consistent with prior results [1]. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0016894-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0016894.g001</object-id><label>Figure 1</label><caption><title><text><SENT sid="6527" pm="."><plain>Sod2-/- erythroid development is characterized by a maturational left shift. </plain></SENT>
</text></title><p><text><SENT sid="6528" pm="."><plain>A. </plain></SENT>
<SENT sid="6529" pm="."><plain>Sod2-/- marrow (right) shows an increased fraction of immature basophilic erythroblasts (R4 gate: 1.9-fold increase) and decreased numbers of reticulocytes and mature RBC (R7 gate: 6-fold decrease), respectively, relative to Sod2+/+ (left). </plain></SENT>
<SENT sid="6530" pm="."><plain>Density dot plots, gated on FSCMed-Hi PI- cells, allowed the quantitative assessment of the maturational stages of differentiating erythroblasts. </plain></SENT>
<SENT sid="6531" pm="."><plain>Region definitions (clockwise): CD71Med TER-119Lo cells or primitive progenitor cells and proerythroblasts (R2), CD71Hi TER-119Lo cells or proerythroblasts and early basophilic erythroblasts (R3), CD71Hi TER-119Hi cells or early and late basophilic erythroblasts (R4), CD71Med TER-119Hi chromatophilic and orthochromatophilic erythroblasts (R5), CD71Lo TER-119Hi cells or late chromatophilic erythroblasts and reticulocytes (R6), and CD71- TER-119+ reticulocytes and mature RBC (R7) (from [29], [30]). B. Bar graph comparing the distribution of Sod2+/+ and Sod2-/- erythroid progenitor cells in the regions defined above in panel A. Significant differences between groups were observed for: R4, 1.9 fold increase in Sod2-/- (26.33±1.70% of gated Sod2-/- [N = 20] vs. 14.10±1.20% Sod2+/+ [N = 17] cells; P&lt;0.0001; % gated cells ± SEM); R7, 5.9 fold decrease in Sod2-/- (0.57±0.14% of gated cells vs. 3.39±0.63%, respectively; P&lt;0.0001; % gated cells ± SEM; N =  same as above). C. Dot plots show the FACS gating strategy used to isolate FSCMed-Hi TER-119+ CD71+ erythroblast populations (R4) for gene expression analysis. </plain></SENT>
<SENT sid="6533" pm="."><plain>Sod2-/- marrow showed erythroid hyperplasia with a 1.6 fold higher number of erythroid progenitors (R4). </plain></SENT>
<SENT sid="6534" pm="."><plain>Dot plots were gated on PI- TER-119+ events and allowed the discrimination of three developmental stages: FSCMed-Hi TER-119+ CD71+ erythroblasts (R4), FSCLo TER-119+ CD71+ reticulocytes (R3) and FSCLo TER-119+ CD71- mature RBC (non-gated on figure). </plain></SENT>
<SENT sid="6535" pm="."><plain>A, B; ***, P&lt;0.0001; Sod2+/+, N = 17; Sod2-/-, N = 20. </plain></SENT>
<SENT sid="6536" pm="."><plain>FACS profiles shown are representative of multiple assays. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0016894.g001"/></fig></SecTag></sec><sec id="s2b"><title><text><SENT sid="6537" pm="."><plain>Microarray-based differential gene expression study of Sod2-/- erythroblasts </plain></SENT>
</text></title><p><text><SENT sid="6538" pm="."><plain>In order to better understand functional consequences of loss of SOD2 during erythropoiesis, we identified gene transcriptional changes in erythroid progenitor cells using cDNA microarray-based gene expression analysis. </plain></SENT>
<SENT sid="6539" pm="."><plain>Erythroblasts were isolated from marrow of reconstituted mice using a sorting gate (figure 1C region R4) that includes regions R4-, R5- and R6-gated events (from figure 1A) encompassing all developing erythroid cells co-expressing TER-119 and CD71 for the preparation of total RNA. </plain></SENT>
<SENT sid="6540" pm="."><plain>By genotype, sorted cells did not show a significant difference in cell size or morphology upon microscopic examination. </plain></SENT>
<SENT sid="6541" pm="."><plain>Total RNA (n = 4 per genotype) was labeled and hybridized on Affymetrix murine arrays to determine relative gene expression between normal and Sod2-/- erythroblasts. </plain></SENT>
</text></p></sec><sec id="s2c"><title><text><SENT sid="6542" pm="."><plain>Analysis of gene expression data </plain></SENT>
</text></title><p><text><SENT sid="6543" pm="."><plain>The GeneSifter program was used to identify and categorize differentially expressed transcripts. </plain></SENT>
<SENT sid="6544" pm="."><plain>Among the 476 differentially expressed transcripts (identified using a minimum fold change of ±1.5 and corrected p value &lt;0.05) 149 were expressed at higher levels in Sod2-/- erythroblasts, while 327 were down-regulated. </plain></SENT>
<SENT sid="6545" pm="."><plain>A scatterplot of comparative gene expression, with selected differentially expressed transcripts identified, is shown in figure 2. </plain></SENT>
<SENT sid="6546" pm="."><plain>The most highly differentially down- and up-regulated transcripts (showing a fold-change ≥±2) are listed in tables 1 (down) and 2 (up). </plain></SENT>
<SENT sid="6547" pm="."><plain>The entire dataset of 476 transcripts can be found in supplementary data table S1. </plain></SENT>
<SENT sid="6548" pm="."><plain>Overall there are more than twice as many down-regulated transcripts in the Sod2-/- samples. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0016894-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0016894.g002</object-id><label>Figure 2</label><caption><title><text><SENT sid="6549" pm="."><plain>Overview of gene expression comparison of Sod2-/- vs. Sod2+/+ erythroblasts. </plain></SENT>
</text></title><p><text><SENT sid="6550" pm="."><plain>Scatterplot highlights genes expressed &gt;1.5 fold higher (red) or lower (green) in Sod2-/- compared to Sod2+/+ cells. </plain></SENT>
<SENT sid="6551" pm="."><plain>X and Y axes plot relative expression values derived from microarray intensities. </plain></SENT>
<SENT sid="6552" pm="."><plain>Spots corresponding to selected highly differentially expressed genes are identified. </plain></SENT>
<SENT sid="6553" pm="."><plain>Among the most highly expressed genes are the hemoglobin alpha and beta chains, that show no difference between Sod2-/- and Sod2+/+ samples. </plain></SENT>
<SENT sid="6554" pm="."><plain>In Sod2-/- erythroblasts, there are more than twice as many transcripts with reduced vs. increased expression. </plain></SENT>
<SENT sid="6555" pm="."><plain>A full listing of differential transcripts (with corrected p&lt;0.05 and fold-change &gt;±1.5) is in table S1. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0016894.g002"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="pone-0016894-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0016894.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="6556" pm="."><plain>List of Expressed Erythroblast Transcripts/Genes with Decreased Expression in Sod2+/+ Compared to Sod2-/- Cells. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0016894-t001-1" xlink:href="pone.0016894.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6557" pm="."><plain>Fold Change </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6558" pm="."><plain>Direction in Sod2+/+ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6559" pm="."><plain>Adjustedp-value </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6560" pm="."><plain>Gene ID </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6561" pm="."><plain>Gene Name </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6562" pm="."><plain>Gene Identifier </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6563" pm="."><plain>UG Cluster </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6564" pm="."><plain>6.24 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6565" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6566" pm="."><plain>0.0134 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6567" pm="."><plain>Gch1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6568" pm="."><plain>GTP cyclohydrolase 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6569" pm="."><plain>NM_008102 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6570" pm="."><plain>Mm.10651 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6571" pm="."><plain>3.48 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6572" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6573" pm="."><plain>0.0241 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6574" pm="."><plain>2410003J06Rik </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6575" pm="."><plain>RIKEN cDNA 2410003J06 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6576" pm="."><plain>AK010362 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6577" pm="."><plain>Mm.379207 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6578" pm="."><plain>3.18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6579" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6580" pm="."><plain>0.0347 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6581" pm="."><plain>Hspa1b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6582" pm="."><plain>Heat shock protein (hsp68) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6583" pm="."><plain>M12573 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6584" pm="."><plain>Mm.372314 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6585" pm="."><plain>2.88 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6586" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6587" pm="."><plain>0.0399 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6588" pm="."><plain>Mthfd2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6589" pm="."><plain>Methylenetetrahydrofolate dehydrogenase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6590" pm="."><plain>BG076333 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6591" pm="."><plain>Mm.443 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6592" pm="."><plain>2.85 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6593" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6594" pm="."><plain>0.0134 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6595" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6596" pm="."><plain>ESTs </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6597" pm="."><plain>BB450769 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6598" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6599" pm="."><plain>2.73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6600" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6601" pm="."><plain>0.0090 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6602" pm="."><plain>E4f1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6603" pm="."><plain>Transcription factor phi AP3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6604" pm="."><plain>NM_007893 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6605" pm="."><plain>Mm.163132 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6606" pm="."><plain>2.68 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6607" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6608" pm="."><plain>0.0048 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6609" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6610" pm="."><plain>Similar to E4F transcription factor 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6611" pm="."><plain>BB027397 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6612" pm="."><plain>Mm.445985 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6613" pm="."><plain>2.66 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6614" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6615" pm="."><plain>0.0129 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6616" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6617" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6618" pm="."><plain>BM201499 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6619" pm="."><plain>Mm.450309 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6620" pm="."><plain>2.59 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6621" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6622" pm="."><plain>0.0136 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6623" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6624" pm="."><plain>ESTs </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6625" pm="."><plain>BM247240 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6626" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6627" pm="."><plain>2.36 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6628" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6629" pm="."><plain>0.0217 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6630" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6631" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6632" pm="."><plain>BM211430 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6633" pm="."><plain>Mm.413311 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6634" pm="."><plain>2.35 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6635" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6636" pm="."><plain>0.0170 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6637" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6638" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6639" pm="."><plain>BB631473 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6640" pm="."><plain>Mm.437948 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6641" pm="."><plain>2.33 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6642" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6643" pm="."><plain>0.0422 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6644" pm="."><plain>Plek2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6645" pm="."><plain>Pleckstrin 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6646" pm="."><plain>NM_013738 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6647" pm="."><plain>Mm.103380 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6648" pm="."><plain>2.31 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6649" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6650" pm="."><plain>0.0170 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6651" pm="."><plain>Epb4.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6652" pm="."><plain>Erythrocyte protein band 4.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6653" pm="."><plain>BB462549 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6654" pm="."><plain>Mm.30038 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6655" pm="."><plain>2.27 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6656" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6657" pm="."><plain>0.0129 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6658" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6659" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6660" pm="."><plain>BB201490 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6661" pm="."><plain>Mm.445692 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6662" pm="."><plain>2.16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6663" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6664" pm="."><plain>0.0218 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6665" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6666" pm="."><plain>DNA segment, Chr 5, ERATO Doi 255, expressed </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6667" pm="."><plain>C79489 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6668" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6669" pm="."><plain>2.16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6670" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6671" pm="."><plain>0.0391 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6672" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6673" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6674" pm="."><plain>BE631223 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6675" pm="."><plain>Mm.472907 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6676" pm="."><plain>2.15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6677" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6678" pm="."><plain>0.0240 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6679" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6680" pm="."><plain>DNA segment, Chr 10, ERATO Doi 276, expressed </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6681" pm="."><plain>BG066654 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6682" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6683" pm="."><plain>2.13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6684" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6685" pm="."><plain>0.0182 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6686" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6687" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6688" pm="."><plain>BF461324 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6689" pm="."><plain>Mm.449557 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6690" pm="."><plain>2.12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6691" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6692" pm="."><plain>0.0129 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6693" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6694" pm="."><plain>ESTs </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6695" pm="."><plain>BB205419 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6696" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6697" pm="."><plain>2.09 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6698" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6699" pm="."><plain>0.0324 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6700" pm="."><plain>Usp32 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6701" pm="."><plain>Ubiquitin specific peptidase 32 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6702" pm="."><plain>BG071170 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6703" pm="."><plain>Mm.178524 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6704" pm="."><plain>2.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6705" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6706" pm="."><plain>0.0331 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6707" pm="."><plain>Cbfa2t3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6708" pm="."><plain>CBF, runt domain, alpha subunit 2, translocated to, 3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6709" pm="."><plain>NM_009824 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6710" pm="."><plain>Mm.194339 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6711" pm="."><plain>2.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6712" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6713" pm="."><plain>0.0428 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6714" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6715" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6716" pm="."><plain>BB471309 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6717" pm="."><plain>Mm.406286 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6718" pm="."><plain>2.03 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6719" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6720" pm="."><plain>0.0347 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6721" pm="."><plain>Malat1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6722" pm="."><plain>Metastasis associated lung adeno-Ca transcript 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6723" pm="."><plain>AK020483 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6724" pm="."><plain>Mm.298256 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6725" pm="."><plain>2.03 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6726" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6727" pm="."><plain>0.0397 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6728" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6729" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6730" pm="."><plain>BM240223 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6731" pm="."><plain>Mm.438431 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6732" pm="."><plain>2.02 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6733" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6734" pm="."><plain>0.0170 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6735" pm="."><plain>Clcn3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6736" pm="."><plain>Chloride channel 3, transcript variant a, </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6737" pm="."><plain>BB328803 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6738" pm="."><plain>Mm.259751 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6739" pm="."><plain>2.01 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6740" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6741" pm="."><plain>0.0399 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6742" pm="."><plain>Per1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6743" pm="."><plain>Period homolog 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6744" pm="."><plain>AF022992 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6745" pm="."><plain>Mm.7373 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6746" pm="."><plain>2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6747" pm="."><plain>Down </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6748" pm="."><plain>0.0397 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6749" pm="."><plain>D930015E06Rik </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6750" pm="."><plain>RIKEN cDNA D930015E06 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6751" pm="."><plain>BB547420 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6752" pm="."><plain>Mm.28838 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p><text><SENT sid="6753" pm="."><plain>(Fold Change ≥2 and corrected p&lt;0.05.). </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="pone-0016894-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0016894.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="6754" pm="."><plain>List of Expressed Erythroblast Transcripts/Genes with Increased Expression in Sod2+/+ Compared to Sod2-/- Cells. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0016894-t002-2" xlink:href="pone.0016894.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6755" pm="."><plain>Fold Change </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6756" pm="."><plain>Direction in Sod2+/+ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6757" pm="."><plain>Adjustedp-value </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6758" pm="."><plain>Gene ID </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6759" pm="."><plain>Gene Name </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6760" pm="."><plain>Gene Identifier </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6761" pm="."><plain>UG Cluster </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6762" pm="."><plain>20.11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6763" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6764" pm="."><plain>0.0008 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6765" pm="."><plain>Ift140 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6766" pm="."><plain>Intraflagellar transport 140 homolog </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6767" pm="."><plain>NM_134126 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6768" pm="."><plain>Mm.32802 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6769" pm="."><plain>4.46 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6770" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6771" pm="."><plain>0.0493 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6772" pm="."><plain>Slc15a2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6773" pm="."><plain>Solute carrier family 15 (H+/peptide transporter) member 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6774" pm="."><plain>NM_021301 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6775" pm="."><plain>Mm.281804 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6776" pm="."><plain>3.96 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6777" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6778" pm="."><plain>0.0397 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6779" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6780" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6781" pm="."><plain>AW493533 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6782" pm="."><plain>Mm.441111 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6783" pm="."><plain>3.54 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6784" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6785" pm="."><plain>0.0129 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6786" pm="."><plain>Unkl </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6787" pm="."><plain>Unkempt-like </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6788" pm="."><plain>AK004898 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6789" pm="."><plain>Mm.267353 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6790" pm="."><plain>3.23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6791" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6792" pm="."><plain>0.0297 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6793" pm="."><plain>Aldh1a7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6794" pm="."><plain>Aldehyde dehydrogenase family 1, subfamily A7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6795" pm="."><plain>NM_011921 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6796" pm="."><plain>Mm.14609 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6797" pm="."><plain>3.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6798" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6799" pm="."><plain>0.0379 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6800" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6801" pm="."><plain>murine leukemia retrovirus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6802" pm="."><plain>BG297038 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6803" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6804" pm="."><plain>2.71 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6805" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6806" pm="."><plain>0.0420 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6807" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6808" pm="."><plain>2,3-cyclic nucleotide 3 phosphodiesterase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6809" pm="."><plain>BB251922 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6810" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6811" pm="."><plain>2.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6812" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6813" pm="."><plain>0.0347 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6814" pm="."><plain>Cd79a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6815" pm="."><plain>CD79A antigen </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6816" pm="."><plain>NM_007655 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6817" pm="."><plain>Mm.1355 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6818" pm="."><plain>2.55 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6819" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6820" pm="."><plain>0.0440 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6821" pm="."><plain>Cdk4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6822" pm="."><plain>Cyclin-dependent kinase 4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6823" pm="."><plain>NM_009870 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6824" pm="."><plain>Mm.6839 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6825" pm="."><plain>2.54 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6826" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6827" pm="."><plain>0.0391 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6828" pm="."><plain>Spib </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6829" pm="."><plain>Ets transcription factor Spi-B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6830" pm="."><plain>BM244106 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6831" pm="."><plain>Mm.8012 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6832" pm="."><plain>2.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6833" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6834" pm="."><plain>0.0411 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6835" pm="."><plain>Selenbp2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6836" pm="."><plain>Selenium binding protein 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6837" pm="."><plain>NM_019414 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6838" pm="."><plain>Mm.225405 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6839" pm="."><plain>2.37 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6840" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6841" pm="."><plain>0.0241 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6842" pm="."><plain>Scd1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6843" pm="."><plain>Strain BALB/c stearoyl-coenzyme A desaturase 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6844" pm="."><plain>NM_009127 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6845" pm="."><plain>Mm.267377 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6846" pm="."><plain>2.33 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6847" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6848" pm="."><plain>0.0493 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6849" pm="."><plain>Cd79b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6850" pm="."><plain>CD79B antigen </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6851" pm="."><plain>NM_008339 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6852" pm="."><plain>Mm.2987 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6853" pm="."><plain>2.26 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6854" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6855" pm="."><plain>0.0170 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6856" pm="."><plain>Tgtp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6857" pm="."><plain>T-cell specific GTPase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6858" pm="."><plain>NM_011579 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6859" pm="."><plain>Mm.15793 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6860" pm="."><plain>2.25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6861" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6862" pm="."><plain>0.0428 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6863" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6864" pm="."><plain>Transcribed locus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6865" pm="."><plain>BB534670 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6866" pm="."><plain>Mm.406799 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6867" pm="."><plain>2.13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6868" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6869" pm="."><plain>0.0170 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6870" pm="."><plain>Cnp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6871" pm="."><plain>2,3-cyclic nucleotide 3 phosphodiesterase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6872" pm="."><plain>M58045 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6873" pm="."><plain>Mm.15711 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6874" pm="."><plain>2.13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6875" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6876" pm="."><plain>0.0170 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6877" pm="."><plain>Hmgn1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6878" pm="."><plain>High mobility group nucleosomal binding domain 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6879" pm="."><plain>NM_008251 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6880" pm="."><plain>Mm.2756 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6881" pm="."><plain>2.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6882" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6883" pm="."><plain>0.0347 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6884" pm="."><plain>Msh6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6885" pm="."><plain>MutS homolog 6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6886" pm="."><plain>U42190 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6887" pm="."><plain>Mm.18210 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6888" pm="."><plain>2.08 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6889" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6890" pm="."><plain>0.0396 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6891" pm="."><plain>Car1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6892" pm="."><plain>Carbonic anhydrase 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6893" pm="."><plain>BC011223 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6894" pm="."><plain>Mm.273195 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6895" pm="."><plain>2.07 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6896" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6897" pm="."><plain>0.0315 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6898" pm="."><plain>Ifit1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6899" pm="."><plain>Interferon-induced protein with tetratricopeptide repeats 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6900" pm="."><plain>NM_008331 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6901" pm="."><plain>Mm.439751 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6902" pm="."><plain>2.07 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6903" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6904" pm="."><plain>0.0428 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6905" pm="."><plain>2900010J23Rik </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6906" pm="."><plain>RIKEN cDNA 2900010J23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6907" pm="."><plain>BI144310 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6908" pm="."><plain>Mm.27344 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6909" pm="."><plain>2.06 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6910" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6911" pm="."><plain>0.0493 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6912" pm="."><plain>Tmem179b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6913" pm="."><plain>Transmembrane protein 179B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6914" pm="."><plain>NM_026325 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6915" pm="."><plain>Mm.45155 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6916" pm="."><plain>2.06 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6917" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6918" pm="."><plain>0.0170 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6919" pm="."><plain>Lgals9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6920" pm="."><plain>Lectin, galactose binding, soluble 9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6921" pm="."><plain>NM_010708 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6922" pm="."><plain>Mm.341434 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6923" pm="."><plain>2.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6924" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6925" pm="."><plain>0.0347 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6926" pm="."><plain>C1qbp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6927" pm="."><plain>Complement component 1, q subcomponent binding protein </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6928" pm="."><plain>NM_007573 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6929" pm="."><plain>Mm.30049 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6930" pm="."><plain>2.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6931" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6932" pm="."><plain>0.0347 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6933" pm="."><plain>Fam132a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6934" pm="."><plain>Family with sequence similarity 132, member A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6935" pm="."><plain>NM_026125 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6936" pm="."><plain>Mm.29140 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6937" pm="."><plain>2.02 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6938" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6939" pm="."><plain>0.0312 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6940" pm="."><plain>Hspb6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6941" pm="."><plain>Heat shock protein, alpha-crystallin-related, B6 (Hspb6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6942" pm="."><plain>BB755506 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6943" pm="."><plain>Mm.34885 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="6944" pm="."><plain>2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6945" pm="."><plain>Up </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6946" pm="."><plain>0.0241 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6947" pm="."><plain>Hn1l </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6948" pm="."><plain>Hematological and neurological expressed 1-like </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6949" pm="."><plain>AV116987 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="6950" pm="."><plain>Mm.371601 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label/><p><text><SENT sid="6951" pm="."><plain>(Fold Change ≥2 and corrected p&lt;0.05.). </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="6952" pm="."><plain>We used gene ontology/pathway analysis [31] to identify patterns of gene expression change characteristic of specific pathways or biological functions affected by SOD2-deficiency. </plain></SENT>
<SENT sid="6953" pm="."><plain>The largest gene sets identified as significantly altered (with a Z-score &gt;±2) [32] in Sod2-/- erythroblasts comprised metabolic pathways with a direct role in mitochondrial metabolism or biogenesis. </plain></SENT>
<SENT sid="6954" pm="."><plain>Nearly every enzyme in the tricarboxylic acid (TCA) cycle was down-regulated at the transcriptional level (figure 3a). </plain></SENT>
<SENT sid="6955" pm="."><plain>The exception was the enzyme phosphoenolpyruvate carboxykinase 2 (Pck2), a regulator of substrate flow between the TCA cycle and glycolysis/gluconeogenesis. </plain></SENT>
<SENT sid="6956" pm="."><plain>Similarly, loss of SOD2 profoundly effects transcription of multiple nuclear-encoded components of all 5 mitochondrial respiratory chain complexes (figure 3b). </plain></SENT>
<SENT sid="6957" pm="."><plain>Mitochondrial protein synthesis is also targeted, with 42 nuclear encoded ribosomal protein genes coordinately down-regulated in Sod2-/- erythroblasts (figure S1 shows a heat map of mitochondrial ribosomal gene expression; all down-regulated ≥1.2 fold with corrected p≤0.05). </plain></SENT>
<SENT sid="6958" pm="."><plain>Additional pathways that differ between Sod2+/+ and Sod2-/- erythroblasts include spliceosome, DNA repair and replication, purine and pyrimidine metabolism and gene sets associated with Huntington's and Parkinson's diseases (supplementary tables S2 and S3 list all pathways that differ between Sod2+/+ and Sod2-/- with a Z-score &gt; ±2). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0016894-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0016894.g003</object-id><label>Figure 3</label><caption><title><text><SENT sid="6959" pm="."><plain>Sod2-/- cells show decreased expression of multiple components of the TCA cycle and Electron Transport Chain. </plain></SENT>
</text></title><p><text><SENT sid="6960" pm="."><plain>A. </plain></SENT>
<SENT sid="6961" pm="."><plain>Schematic of TCA cycle highlights those enzymes with reduced transcript levels. </plain></SENT>
<SENT sid="6962" pm="."><plain>Degree of shading reflects the degree of transcript expression change. </plain></SENT>
<SENT sid="6963" pm="."><plain>The associated table shows enzyme name and fold change observed. </plain></SENT>
<SENT sid="6964" pm="."><plain>Nearly every enzyme in the pathway shows a statistically significant reduction in transcription, although the fold-change is modest. B. Schematic diagram of ETC complexes I-IV and ATP synthase highlights nuclear encoded components with decreased expression in Sod2-/- cells. </plain></SENT>
<SENT sid="6966" pm="."><plain>The accompanying table lists specific subunit names along with the fold change observed. </plain></SENT>
<SENT sid="6967" pm="."><plain>Each complex shows decreased transcription of one or more nuclear encoded subunits. </plain></SENT>
<SENT sid="6968" pm="."><plain>All highlighted subunits in panels A and B showed statistically significant differential expression (p&lt;0.05), with fold-change as indicated in table or by grey-scale. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0016894.g003"/></fig></SecTag><p><text><SENT sid="6969" pm="."><plain>Genes involved in hemoglobin biosynthesis, iron metabolism or identified as known causes of sideroblastic anemia were queried for differential expression. </plain></SENT>
<SENT sid="6970" pm="."><plain>No significant differences were observed for most genes involved in heme biosynthesis including ALAS-2 and alpha and beta globin chains–which as expected were among the most highly expressed transcripts in erythroblasts (figure 2). </plain></SENT>
<SENT sid="6971" pm="."><plain>A single transcript (Riken cDNA A230051G13) encoding a putative aminomethyltransferase involved in heme biosynthesis was expressed at higher levels in Sod2+/+ cells (see supplemental figure S2). </plain></SENT>
<SENT sid="6972" pm="."><plain>Two genes involved in iron metabolism, transferrin receptor (Tfrc) and ATP binding cassette family member b7 (ABCb7) were differentially expressed. Tfrc, the cellular gatekeeper for iron, was expressed at higher levels in Sod2-/- cells (figure 4) at both the mRNA and protein levels. ABCb7, previously shown to be mutated in X-linked sideroblastic anemia with ataxia (XLSA/A—OMIM 301310) is decreased in Sod2-/- cells (1.6 fold decrease, p = 0.02, unpaired t test). </plain></SENT>
<SENT sid="6973" pm="."><plain>No other genes associated with iron metabolism, heme biosynthesis or hereditary sideroblastic anemia showed significantly different expression between groups. </plain></SENT>
<SENT sid="6974" pm="."><plain>(supplemental figure S2 shows expression heat maps and the list of genes from these analyses). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0016894-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0016894.g004</object-id><label>Figure 4</label><caption><title><text><SENT sid="6975" pm="."><plain>Validation of Microarray Results at Protein Level (CD71) and by qPCR. </plain></SENT>
</text></title><p><text><SENT sid="6976" pm="."><plain>A. </plain></SENT>
<SENT sid="6977" pm="."><plain>Transferrin Receptor Expression: Smoothed histograms excluding dead cells display (i) CD71, (ii) TER-119, (iii) FSC height vs. cell counts. </plain></SENT>
<SENT sid="6978" pm="."><plain>Bone marrow cell suspensions were labeled with anti-TER-119, -CD71 or isotype control mAbs plus propidium iodide, and were assayed by FACS. </plain></SENT>
<SENT sid="6979" pm="."><plain>Events were gated on FSCMed-Hi PI- TER-119+ cells. </plain></SENT>
<SENT sid="6980" pm="."><plain>Staining specificity was determined by comparison with staining using an isotype control mAb for CD71 (not shown). </plain></SENT>
<SENT sid="6981" pm="."><plain>Sod2+/+ and Sod2-/- cells express similar levels of TER-119 antigen (1319±145.30 vs. 1352±140.60) and have similar forward scatter profiles (103.80±1.35 vs. 106.50±1.64), yet Sod2-/- cells show a 1.6-fold increase in transferrin receptor 1 (CD71) expression (528.80±51.07 vs. 851.10±57.29, Sod2+/+ vs. Sod2-/-). </plain></SENT>
<SENT sid="6982" pm="."><plain>This increase appears to represent both a developmental shift (see figure 1A), and an increase in absolute expression within individual cells. </plain></SENT>
<SENT sid="6983" pm="."><plain>Values presented are geometric mean fluorescence intensity (Geo MFI) ± SEM; Sod2-/-, N = 20; Sod2+/+, N = 17; ***, P&lt;0.0001. B. qPCR validation of microarray study: Graph shows the relative expression of 14 transcripts determined by qPCR. </plain></SENT>
<SENT sid="6984" pm="."><plain>Expression levels in Sod2-/- erythroblasts (grey) are presented relative to Sod2+/+ samples as calibrator (black); the latter being given an expression level of 1 (Log10(1) = 0), Log10 transformed and vertically stacked. </plain></SENT>
<SENT sid="6985" pm="."><plain>TaqMan assays were chosen so that they covered a wide range of expression from the most down-regulated to the most up-regulated transcripts in Sod2-/- erythroblasts. </plain></SENT>
<SENT sid="6986" pm="."><plain>Results were normalized to the expression of eukaryotic 18S rRNA as endogenous control. </plain></SENT>
<SENT sid="6987" pm="."><plain>13/14 transcripts were significantly different between Sod2+/+ and Sod2-/- samples. </plain></SENT>
<SENT sid="6988" pm="."><plain>All transcripts showed the expected direction of differential expression based upon microarray results. </plain></SENT>
<SENT sid="6989" pm="."><plain>RQ, relative quantity (X axis); mean ± SEM; N = 4 biological replicates per genotype, run in technical triplicates; figure indicates p values from unpaired, 2 tailed t test. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0016894.g004"/></fig></SecTag></sec><sec id="s2d"><title><text><SENT sid="6990" pm="."><plain>Microarray validation at the transcript and protein levels </plain></SENT>
</text></title><p><text><SENT sid="6991" pm="."><plain>Expression at the gene and protein level of CD71, transferrin receptor, was of particular interest as SOD2 deficient cells, similar to sideroblasts in patients with SA, show iron overload in the presence of an obvious defect in iron utilization. </plain></SENT>
<SENT sid="6992" pm="."><plain>The higher expression of Tfrc found in Sod2-/- erythroblasts was verified both by FACS analysis of CD71 surface expression on bone marrow cell suspensions (figure 4a) and by qPCR (figure 4b). </plain></SENT>
<SENT sid="6993" pm="."><plain>Increased expression of CD71 was not due to differences in cell size, as normal and SOD2 deficient erythroid cells showed similar forward scatter profiles and expressed comparable amounts of the Ter119 surface antigen, yet showed a 1.6 fold increase in transferrin receptor 1 (CD71) surface expression, when comparing geometric means of fluorescence intensity values. </plain></SENT>
</text></p><p><text><SENT sid="6994" pm="."><plain>Array data were validated by performing TaqMan Gene Expression Assays on total RNA samples from independently prepared TER-119+ CD71+ erythroblasts. </plain></SENT>
<SENT sid="6995" pm="."><plain>13/14 transcripts tested by qPCR showed significant differential expression between Sod2-/- and Sod2+/+ samples (2 with p&lt;0.05, 11 with p&lt;0.0001) and all transcripts showed the expected direction of change when comparing Sod2-/- and Sod2+/+ cells (figure 4b). </plain></SENT>
<SENT sid="6996" pm="."><plain>The validation set included genes with high, intermediate and low expression levels, as well as the most highly up and down regulated transcripts. </plain></SENT>
<SENT sid="6997" pm="."><plain>Among the validation set are genes with highly differential expression, but no previously described role in red cell development or physiology—such as synuclein α Snca–2 fold up, intraflagellar transport protein 140 (Ift140—20 fold down), GTP cyclohydrolase (Gch1—6 fold up) and tuberous sclerosis 2 (Tsc2—2 fold down). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="s3"><title><text><SENT sid="6998" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="6999" pm="."><plain>In this study we have evaluated gene expression changes in erythroblasts that result from knockout of the antioxidant protein SOD2 in hematopoietic tissues—a model previously shown to have many features of congenital or acquired sideroblastic anemia. </plain></SENT>
<SENT sid="7000" pm="."><plain>Comparative FACS analysis using erythroid specific markers (Ter119 and CD71—figure 1) demonstrates a maturational shift in SOD2 deficient marrow, with more immature cells, particularly basophilic erythroblasts, relative to wild-type marrows. </plain></SENT>
<SENT sid="7001" pm="."><plain>This is consistent with prior work showing erythroid hyperplasia in spleen and marrow of recipients of Sod2-/- cells [1]. </plain></SENT>
</text></p><p><text><SENT sid="7002" pm="."><plain>SOD2-deficiency had profound effects on transcription of genes involved in mitochondrial metabolism, with multiple transcripts encoding proteins involved in oxidative phosphorylation, ATP synthesis, TCA cycle and mitochondrial biogenesis down-regulated in Sod2-/- erythroblasts (figure 3). </plain></SENT>
<SENT sid="7003" pm="."><plain>An analogous global decline in activity was found when measuring mitochondrial respiratory complex activity in tissues of Sod2-/- neonates prior to death [24], [33]. </plain></SENT>
<SENT sid="7004" pm="."><plain>In particular, nuclear-encoded components of all 5 mitochondrial respiratory complexes showed reduced transcript levels, as did multiple enzymes in the TCA cycle. </plain></SENT>
<SENT sid="7005" pm="."><plain>An exception was the TCA cycle enzyme phosphoenolpyruvate carboxykinase 2 (Pck), that showed an increase in expression in SOD2 deficient cells. </plain></SENT>
<SENT sid="7006" pm="."><plain>Pck converts the TCA cycle anion oxaloacetate to phosphoenolpyruvate, which can in turn be converted to pyruvate by pyruvate kinase (PK) or to glucose. </plain></SENT>
<SENT sid="7007" pm="."><plain>Increased expression of Pck2 suggests that substrates are being shunted away from the TCA cycle toward glycolysis/gluconeogenesis in Sod2-/- cells [34]. </plain></SENT>
</text></p><p><text><SENT sid="7008" pm="."><plain>A major mechanism underlying the development of mitochondria-related diseases is thought to be an increase in intracellular oxidative stress resulting from impairment of the mitochondrial electron transport chain (ETC) [35], [36]. </plain></SENT>
<SENT sid="7009" pm="."><plain>Our microarray results show that in the context of SOD2 deficiency, oxidant stress leads to a broad down-regulation of genes encoding components of the respiratory chain. </plain></SENT>
<SENT sid="7010" pm="."><plain>This may be due to a direct effect of superoxide on a signaling pathway between the nucleus and mitochondria, or may result from a decline in the function of oxidant sensitive components of the electron transport chain (such as Fe:S containing proteins)—resulting in a metabolic imbalance that triggers mitochondrial-to-nuclear communication. </plain></SENT>
</text></p><p><text><SENT sid="7011" pm="."><plain>Widespread down regulation of expression of nuclear encoded mitochondrial genes/proteins suggests engagement of a feedback loop controlling transcription of nuclear-encoded mitochondrial proteins. </plain></SENT>
<SENT sid="7012" pm="."><plain>Candidate components of such a feedback loop include the related nuclear coactivators PGC1α, PGC1β and PPRC1, which regulate expression of many proteins involved in oxidative phosphorylation and mitochondrial biogenesis [37], [38], [39], including many genes in the set of down regulated messages in Sod2-/- erythroblasts. </plain></SENT>
<SENT sid="7013" pm="."><plain>A prior study investigating erythroid development from hematopoietic stem cells deficient in the tumor suppressor Rb implicated PGC1β as a regulator of erythroid development [40]. </plain></SENT>
<SENT sid="7014" pm="."><plain>PGC1α and PGC1β transcript levels were very low in erythroblasts and did not differ between normal and Sod2-/- cells either in microarray or subsequent qPCR experiments (data not shown). </plain></SENT>
<SENT sid="7015" pm="."><plain>Expression of the related coactivator, PPRC1 [37] was both higher, and differential when comparing Sod2-/- and normal erythroblasts on microarray (1.6 fold &gt; in Sod2+/+ vs. Sod2-/-, P&lt;0.05) implicating PPRC1 as a candidate regulator of mitochondrial biogenesis during erythroid development. </plain></SENT>
<SENT sid="7016" pm="."><plain>While microarray analysis does not assess transcription of mitochondrial DNA-encoded subunits of the respiratory chain, we also found reduced expression (1.8-fold, with adjusted P&lt;0.02) of the critical nuclear encoded mitochondrial transcription factor A (Tfam) in Sod2-/- erythroblasts. Tfam is required for the expression of mitochondrial DNA-encoded genes, and is itself a target of PGC1α [41] and, by analogy, a potential target of related family members PGC1β and PPRC1. </plain></SENT>
<SENT sid="7017" pm="."><plain>One prediction that follows from decreased expression of Tfam would be a global decrease in expression of mitochondrial encoded protein subunits of the ETC in SOD2 deficient cells. </plain></SENT>
<SENT sid="7018" pm="."><plain>Also consistent with the theme of decreased mitochondrial biogenesis is the statistically significant, but modest (1.2 to 1.6 fold) decrease in transcription of multiple nuclear encoded mitochondrial ribosomal protein genes in Sod2-/- cells (supplementary figure S1). </plain></SENT>
</text></p><p><text><SENT sid="7019" pm="."><plain>Like human sideroblasts, SOD2 deficient erythroblasts do not effectively utilize iron creating a paradoxical situation in which cells are functionally iron-deficient despite (intramitochondrial) iron overload. </plain></SENT>
<SENT sid="7020" pm="."><plain>Microarray data revealed two differentially expressed transcripts involved in iron homeostasis, Tfrc–encoding transferrin receptor 1–that is expressed at higher levels in Sod2-/- cells (figure 4b), and ABCb7—a mitochondrial membrane localized solute transport protein necessary for iron:sulfur cluster biogenesis. </plain></SENT>
<SENT sid="7021" pm="."><plain>Increased expression of Tfrc is likely to facilitate the observed dramatic increase in iron content of SOD2 deficient cells by enhancing iron delivery. </plain></SENT>
<SENT sid="7022" pm="."><plain>In both figure 1A and figure 4A, we show increased Tfrc protein expression by flow cytometric assay in SOD2 deficient erythroid progenitors. </plain></SENT>
<SENT sid="7023" pm="."><plain>This increased expression reflects both the over-representation of basophilic erythroblasts (which are CD71 high by definition) in the SOD2 deficient marrow, and an incremental increase of Tfrc expression within Sod2-/- cells at this developmental stage. </plain></SENT>
<SENT sid="7024" pm="."><plain>This incremental increase in Tfrc expression may be mediated by changes in intracellular iron regulatory protein function. </plain></SENT>
<SENT sid="7025" pm="."><plain>Decreased expression of ABCb7 (down-regulated in SOD2 deficient cells 1.7-fold) may also exert an effect on iron metabolism through a reduction in Fe:S cluster assembly—and thereby impact iron homeostasis by altering the level of iron regulatory protein 1 (IRP1). </plain></SENT>
<SENT sid="7026" pm="."><plain>Under conditions of iron deficiency, IRP1 activity increases as the apo protein (lacking an Fe:S cluster) accumulates. </plain></SENT>
<SENT sid="7027" pm="."><plain>IRP's bind to regulatory sequences in the Tfrc mRNA 3′ untranslated region and stabilize the messenger RNA—promoting production of transferrin receptor protein [42], [43], [44] thereby increasing iron delivery. </plain></SENT>
<SENT sid="7028" pm="."><plain>Decreased transcription of ABCb7 has been reported in CD34+ cells isolated from MDS patients with idiopathic acquired SA (RARS), suggesting that ABCb7 is a critical, perhaps necessary target for the derangement of iron metabolism that leads to generation of ringed sideroblasts [45]. </plain></SENT>
<SENT sid="7029" pm="."><plain>Interestingly, we find that Ciao1 [46], [47], a gene encoding a second protein required for a late step of iron:sulfur cluster assembly, is also down-regulated in Sod2-/- cells (1.6-fold; p&lt;0.0005 unpaired t test). </plain></SENT>
<SENT sid="7030" pm="."><plain>The same argument can be made that reduced Ciao1 activity has potential to alter erythroid iron metabolism by tipping the balance toward generation of the apo protein, IRP1. </plain></SENT>
</text></p><p><text><SENT sid="7031" pm="."><plain>At the level of gene expression profiling, the most prominent effect of loss of SOD2 is a broad down-regulation of multiple aspects of mitochondrial metabolism and biogenesis. </plain></SENT>
<SENT sid="7032" pm="."><plain>This is consistent with current knowledge regarding causes of hereditary SA—where mutations affecting proteins that localize to mitochondria, or mitochondrial DNA itself have been shown to be causal. </plain></SENT>
<SENT sid="7033" pm="."><plain>SA is much more common later in life in the context of myelodysplasia, where etiology remains uncertain. </plain></SENT>
<SENT sid="7034" pm="."><plain>Our results demonstrate that mitochondrial dysfunction (of diverse etiology) can be a primary event in development in SA. </plain></SENT>
<SENT sid="7035" pm="."><plain>In Sod2-/- erythroblasts oxidative stress affects erythroid-specific transcriptional mechanism(s) that regulate expression of nuclear encoded mitochondrial proteins. </plain></SENT>
<SENT sid="7036" pm="."><plain>One consequence of such dysfunction is altered iron metabolism secondary to impaired iron:sulfur cluster synthesis resulting from down-regulation of ABCb7 and Ciao1—which impacts both mitochondrial iron utilization and regulation of iron metabolism. </plain></SENT>
<SENT sid="7037" pm="."><plain>Identification of components of the mitochondrial biogenesis pathway active during erythroid differentiation will be an important step toward improving our understanding of the etiology of SA and will provide additional insights into the relationship between mitochondrial dysfunction and development of anemia. </plain></SENT>
<SENT sid="7038" pm="."><plain>Novel insights into pathogenesis of sideroblastic anemia may come from evaluation of the function of additional candidate genes identified as strongly differentially expressed between normal and Sod2-/- erythroblasts, but with no previously defined role in erythroid development. </plain></SENT>
<SENT sid="7039" pm="."><plain>Evaluation of these loci in both hereditary and acquired SA cases that lack mutations in previously identified SA genes may identify novel mutations associated with this disorder. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="s4"><title><text><SENT sid="7040" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec id="s4a"><title><text><SENT sid="7041" pm="."><plain>Ethics Statement </plain></SENT>
</text></title><p><text><SENT sid="7042" pm="."><plain>All animal experiments were conducted under an approved protocol (ARC 06-0339) approved by the TSRI IACUC committee. </plain></SENT>
<SENT sid="7043" pm="."><plain>All work complies with relevant federal and state regulations concerning use of animals. </plain></SENT>
</text></p></sec><sec id="s4b"><title><text><SENT sid="7044" pm="."><plain>Mice and reagents </plain></SENT>
</text></title><p><text><SENT sid="7045" pm="."><plain>Female B6 mice reconstituted with Sod2+/+ or Sod2-/- HSC were generated as previously described [1]. </plain></SENT>
<SENT sid="7046" pm="."><plain>Hematopoietic chimeric animals were tested for anemia by assaying hematocrit and reticulocyte counts. </plain></SENT>
<SENT sid="7047" pm="."><plain>Marrow was taken from femurs, tibias, pelvic girdles and humerus after Halothane (Halocarbon Laboratories, River Edge, NJ) vapor terminal inhalation. </plain></SENT>
<SENT sid="7048" pm="."><plain>All experiments were conducted under an approved protocol (ARC 06-339) approved by the TSRI IACUC committee. </plain></SENT>
<SENT sid="7049" pm="."><plain>All work complies with relevant federal and state regulations concerning use of animals. </plain></SENT>
<SENT sid="7050" pm="."><plain>All monoclonal antibodies (mAbs) were purchased from Pharmingen (BD Biosciences, San Jose, CA) save a FITC-rat IgG1, κ isotype control mAb (eBioscience, Inc., San Diego, CA). </plain></SENT>
<SENT sid="7051" pm="."><plain>LS &amp; LD MACS columns and MidiMACS separator units were purchased from Miltenyi Biotech (Auburn, CA, USA); and phenol red–free RPMI 1640 media from Invitrogen (Carlsbad, CA, USA). </plain></SENT>
<SENT sid="7052" pm="."><plain>Propidium iodide (PI) and Hybri-Max RBC lysing buffer were purchased from Sigma-Aldrich (St. Louis, MO, USA). </plain></SENT>
</text></p></sec><sec id="s4c"><title><text><SENT sid="7053" pm="."><plain>Erythroblast sorting for microarray </plain></SENT>
</text></title><p><text><SENT sid="7054" pm="."><plain>Bone marrow cell suspensions were labeled with a purified anti-CD16/32 mAb for cell surface Fc fragment receptors (FcR) saturation, FITC-conjugated anti-CD71 and PE-conjugated anti-TER-119 mAbs in ice-cold fluorescence-activated cell sorting (FACS) buffer (2 mM EDTA: 0.5% BSA: PBS). </plain></SENT>
<SENT sid="7055" pm="."><plain>Cells were resuspended in sorting buffer (1 mM EDTA: 25 mM HEPES: 1% FCS: 10 µg/ml PI: PBS). </plain></SENT>
<SENT sid="7056" pm="."><plain>Two pairs of Sod2+/+ and Sod2-/- samples were sorted in parallel using two FACSDiva and two FACSAria sorters (BD Biosciences). </plain></SENT>
<SENT sid="7057" pm="."><plain>Ter119+, CD71+ erythroblasts corresponding to gate R4 in Figure 1C were used for microarray analysis. </plain></SENT>
</text></p></sec><sec id="s4d"><title><text><SENT sid="7058" pm="."><plain>Positive selection of TER-119+ erythroid progenitors for quantitative real-time RT-PCR (qPCR) </plain></SENT>
</text></title><p><text><SENT sid="7059" pm="."><plain>RBC-depleted bone marrow cell suspensions were labeled with a biotinylated TER-119 mAb; TER-119+ cells were pulled down with streptavidin MicroBeads (Miltenyi Biotec) according to the manufacturer's instructions. </plain></SENT>
<SENT sid="7060" pm="."><plain>Purity and cell morphology were evaluated by FACS analysis and microscopic examination of Wright-Giemsa-stained sorted cells cytospun onto slides, respectively. </plain></SENT>
<SENT sid="7061" pm="."><plain>Ter-119+ cells represented 85.78%±1.6% of magnetically-purified cells from whole marrow suspensions with 81.94%±3.23% viability (N = 7; trypan blue exclusion; not shown). </plain></SENT>
<SENT sid="7062" pm="."><plain>We extracted and average of 8.29 (±1.16) micrograms total RNA from 18.82 (±3.90)×106 purified erythroid progenitors (N = 7; not shown) as material for validation using RT-qPCR reactions. </plain></SENT>
</text></p></sec><sec id="s4e"><title><text><SENT sid="7063" pm="."><plain>FACS analysis </plain></SENT>
</text></title><p><text><SENT sid="7064" pm="."><plain>Cell suspensions were labeled with purified anti-CD16/32 (FcR saturation), FITC-conjugated anti-CD71 and PE-conjugated anti-TER-119 mAbs in ice-cold FACS buffer. </plain></SENT>
<SENT sid="7065" pm="."><plain>10 µg/ml PI was added prior to analysis on a FACSCalibur cytometer running CellQuest Pro (BD Biosciences). </plain></SENT>
<SENT sid="7066" pm="."><plain>Gating distinct stages of erythroid development (figure 1A) was based upon scheme of Socolovsky [29]. </plain></SENT>
<SENT sid="7067" pm="."><plain>Anti-CD71 labeling specificity was validated by the use of a FITC-rat IgG1, κ isotype control mAb (eBioscience, San Diego, CA). </plain></SENT>
</text></p></sec><sec id="s4f"><title><text><SENT sid="7068" pm="."><plain>Total RNA extraction from erythroid cells </plain></SENT>
</text></title><p><text><SENT sid="7069" pm="."><plain>Total RNA was extracted using the RNeasy Mini kit (Qiagen, Inc., Valencia, CA) accordingly to the manufacturer's suggested protocol for isolation of Total RNA from animal cells. </plain></SENT>
<SENT sid="7070" pm="."><plain>Briefly, we disrupted and lysed 12.65±1.90 million sorted cells (N = 8) in RLT Buffer, homogenized and sheared genomic DNA through centrifugation on QIAshredder spin columns; we performed on-column DNA digestion with the RNase-Free DNase Set (Qiagen) and eluted total RNA in RNase-free water (Sigma-Aldrich). </plain></SENT>
</text></p></sec><sec id="s4g"><title><text><SENT sid="7071" pm="."><plain>Oligonucleotide arrays </plain></SENT>
</text></title><p><text><SENT sid="7072" pm="."><plain>All experiments were performed using GeneChip Mouse Genome 430 2.0 and GLYCOv2 oligonucleotide arrays (Affymetrix, Santa Clara, CA), as described at <ext-link ext-link-type="uri" xlink:href="http://www.affymetrix.com/products/arrays/specific/mouse430_2.affx">http://www.affymetrix.com/products/arrays/specific/mouse430_2.affx</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.functionalglycomics.org/static/consortium/resources/resourcecoree.shtml">http://www.functionalglycomics.org/static/consortium/resources/resourcecoree.shtml</ext-link>, respectively. </plain></SENT>
<SENT sid="7073" pm="."><plain>GLYCOv2 oligonucleotide arrays are custom GeneChip arrays designed for the Consortium for Functional Glycomics (CFG, <ext-link ext-link-type="uri" xlink:href="http://www.functionalglycomics.org/">http://www.functionalglycomics.org/</ext-link>). </plain></SENT>
</text></p></sec><sec id="s4h"><title><text><SENT sid="7074" pm="."><plain>RNA target preparation and array processing </plain></SENT>
</text></title><sec id="s4h1"><title><text><SENT sid="7075" pm="."><plain>Labeling </plain></SENT>
</text></title><p><text><SENT sid="7076" pm="."><plain>Total RNA from each sample was used to prepare biotinylated target RNA using standard Affymetrix protocol (<ext-link ext-link-type="uri" xlink:href="http://www.affymetrix.com/support/technical/manual/expression_manual.affx">http://www.affymetrix.com/support/technical/manual/expression_manual.affx</ext-link>) as previously described [48]. </plain></SENT>
<SENT sid="7077" pm="."><plain>Briefly, 5 µg of total RNA was used to generate first-strand cDNA by using a T7-linked oligo(dT) primer. </plain></SENT>
<SENT sid="7078" pm="."><plain>After second-strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP (Enzo Life Sciences, Farmingdale, NY). Hybridization: the target cRNA generated from each sample was processed as per manufacturer's recommendation using a GeneChip Instrument System (Affymetrix). </plain></SENT>
<SENT sid="7079" pm="."><plain>Briefly, spike controls were added to 6.7 µg and 10 µg fragmented cRNA before overnight hybridization on GLYCOv2 and 430 2.0 arrays, respectively. Post-processing and scanning: arrays were then washed and stained with streptavidin-phycoerythrin, before being scanned on a ScanArray 3000 (Affymetrix) using default settings and a target intensity of 250 for scaling. Quality control (QC): The amount and quality of starting total RNA and cRNA were checked with a ND-1000 Spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE) and an Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA), respectively, and/or on formaldehyde-containing agarose gels. </plain></SENT>
<SENT sid="7080" pm="."><plain>After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. </plain></SENT>
<SENT sid="7081" pm="."><plain>GAPDH and β-actin 3′/5′ ratios were confirmed to be within acceptable limits although one Sod2-/- specimen, showed slight RNA degradation. </plain></SENT>
<SENT sid="7082" pm="."><plain>Gene Sifter analyses performed with and without this 4th Sod2-/- sample yielded similar results, and all figures/tables are derived from a 4×4 chip comparison. </plain></SENT>
<SENT sid="7083" pm="."><plain>BioB spike controls were found to be present on all chips, with BioC, BioD and CreX also present in increasing intensity. </plain></SENT>
<SENT sid="7084" pm="."><plain>When scaled to a target intensity of 250 using the GeneChip Operating Software (GCOS) v1.3.037 algorithm (Affymetrix), scaling factors for all arrays were within acceptable limits (8.218-12.594 for GLYCOv2 chips, 4.089-7.955 for 430 2.0 arrays), as were background (42-68 for GLYCOv2, 48-67 for 430 2.0), Q values and mean intensities. </plain></SENT>
<SENT sid="7085" pm="."><plain>Details of QC measures can be found at <ext-link ext-link-type="uri" xlink:href="https://www.functionalglycomics.org/glycomics/publicdata/microarray.jsp">https://www.functionalglycomics.org/glycomics/publicdata/microarray.jsp</ext-link>, by clicking on the ‘Raw Data’ icon link for microarray experiment ‘Jeff Friedman 1: Sod2 KO anemic mice’. </plain></SENT>
</text></p></sec><sec id="s4h2"><title><text><SENT sid="7086" pm="."><plain>Microarray data analysis </plain></SENT>
</text></title><p><text><SENT sid="7087" pm="."><plain>Data presented were generated using GeneSifter (VizX Labs, Seattle, WA) based pairwise analysis, RMA-normalized. </plain></SENT>
<SENT sid="7088" pm="."><plain>CEL files (N = 4 Sod2+/+; N = 4 Sod2-/-) and were filtered upon the following criteria: a ±1.5 or 1.2 ratio cutoff (fold change, F.C.), t-test with Benjamini and Hochberg MTC to adjust for false positives, FDR [49], [50] and adjusted P value &lt;0.05. </plain></SENT>
<SENT sid="7089" pm="."><plain>Using these parameters, we found 476 discriminant transcripts at a ±1.5 fold change (supplement  table S1 ), and 2565 at a ±1.2 fold change. </plain></SENT>
<SENT sid="7090" pm="."><plain>MIAME-compliant data discussed in this publication has been deposited at the CFG (<ext-link ext-link-type="uri" xlink:href="https://www.functionalglycomics.org/glycomics/publicdata/microarray.jsp">https://www.functionalglycomics.org/glycomics/publicdata/microarray.jsp</ext-link>; GLYCOv2 arrays), in NCBIs Gene Expression Omnibus (GEO, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>) and is accessible through GEO Series accession number GSE8726 (Mouse Genome 430 2.0 arrays). </plain></SENT>
<SENT sid="7091" pm="."><plain>Gene ontology and KEGG pathway analyses were performed in GeneSifter to identify affected pathways. </plain></SENT>
<SENT sid="7092" pm="."><plain>The entire gene expression dataset (unfiltered for threshold or statistical significance) was used to query expression of sets of genes of interest (for example: heme biosynthesis, sideroblastic anemia, iron metabolism as presented in supplementary data). </plain></SENT>
</text></p></sec><sec id="s4h3"><title><text><SENT sid="7093" pm="."><plain>Two-step TaqMan Gene Expression Assays </plain></SENT>
</text></title><p><text><SENT sid="7094" pm="."><plain>Total RNA was concentrated with a DNA100 SpeedVac Concentrator (Savant) and reverse transcribed using the High-Capacity cDNA reverse transcription (RT) kit (Applied Biosystems Inc., Foster City, CA). </plain></SENT>
<SENT sid="7095" pm="."><plain>We performed quantitative real-time PCR (qPCR) using 30 ng cDNA template and the TaqMan Gene Expression Master Mix (ABI) in singleplex reactions on a 7900HT Fast Real-Time PCR System running SDS 2.3 (ABI) in default thermal cycling conditions and endpoint data collection. </plain></SENT>
<SENT sid="7096" pm="."><plain>QC and amplification specificity of all targets was confirmed by melting curve analysis. </plain></SENT>
<SENT sid="7097" pm="."><plain>Data analysis was performed using the RQ Manager 1.2 software (ABI) in ΔΔCt relative quantification mode. </plain></SENT>
<SENT sid="7098" pm="."><plain>Eukaryotic 18S rRNA was used as endogenous control; results were expressed relative to Sod2+/+ samples as calibrator and being given an expression level of 1 [51]. </plain></SENT>
<SENT sid="7099" pm="."><plain>Average Ct values for both Sod2-/- and control Sod2+/+ samples were based on 4 biological replicates; the Ct value for each biological replicate was the average of technical triplicates. </plain></SENT>
<SENT sid="7100" pm="."><plain>Part numbers of the used assays are shown in supplementary data  table S4 . </plain></SENT>
</text></p></sec></sec><sec id="s4i"><title><text><SENT sid="7101" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="7102" pm="."><plain>Unpaired two-tailed t-tests were performed using GraphPad Prism (GraphPad Software, San Diego, CA); results are shown as mean ± SEM; replicate numbers (N). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="s5"><title><text><SENT sid="7103" pm="."><plain>Supporting Information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0016894.s001"><label>Figure S1</label><caption><p><text><SENT sid="7104" pm="."><plain>Heat Map of Mitochondrial Ribosomal Protein Gene Expression. 42 Distinct nuclear encoded mitochondrial ribosomal protein genes are expressed differentially when comparing Sod2+/+ and Sod2-/- samples. </plain></SENT>
<SENT sid="7105" pm="."><plain>Data were filtered to display transcripts with ≥1.2 fold change and a corrected p value &lt;0.05. </plain></SENT>
<SENT sid="7106" pm="."><plain>Using these criteria, 43/45 significantly different transcripts are down regulated in Sod2-/- erythroblasts. </plain></SENT>
<SENT sid="7107" pm="."><plain>3 of the listed genes appear twice and are represented by 2 distinct probe sets. </plain></SENT>
</text></p><p><text><SENT sid="7108" pm="."><plain>(DOC) </plain></SENT>
</text></p></caption><media xlink:href="pone.0016894.s001.doc"><caption><p><text><SENT sid="7109" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0016894.s002"><label>Figure S2</label><caption><p><text><SENT sid="7110" pm="."><plain>Heat Maps Showing Genes Involved in: Iron Ion Homeostatis, Heme Biosynthesis, or Etiology of Sideroblastic Anemia. Expression of genes annotated as playing a role in iron homeostasis and heme biosynthesis is displayed for both Sod2+/+ and Sod2-/- samples without statistical filtering for fold change or significance. </plain></SENT>
<SENT sid="7111" pm="."><plain>When statistical filters were applied to the set of iron homeostasis genes, ABCb7 and Tfrc were the only genes expressed with a fold change ≥1.5 and p value &lt;0.05. ABCb7 is down in Sod2-/- cells, while Tfrc expression is up. </plain></SENT>
<SENT sid="7112" pm="."><plain>Similarly, genes involved in heme biosynthesis are displayed without filtering on the right. </plain></SENT>
<SENT sid="7113" pm="."><plain>When statistical filters were applied, a putative cDNA (Riken A230051G13) with a proposed role in glycine catabolism and heme biosynthesis was found to be expressed at higher levels in Sod2+/+ cells, meeting the same fold-change and statistical criteria. </plain></SENT>
<SENT sid="7114" pm="."><plain>Finally, genes previously identified as mutated in hereditary sideroblastic anemia were queried for expression. </plain></SENT>
<SENT sid="7115" pm="."><plain>Of these genes, only ABCb7 was (again) found to be significantly differentially expressed. Sod2 appears in the list of iron homeostasis related genes without showing differential expression. </plain></SENT>
<SENT sid="7116" pm="."><plain>This reflects detection of expressed (but deleted for exon 3, and therefore nonfunctional [24]) mRNA in the Sod2-/- cells, as some of the probesets on the microarray for detecting this gene are outside of the deleted exons. </plain></SENT>
</text></p><p><text><SENT sid="7117" pm="."><plain>(DOC) </plain></SENT>
</text></p></caption><media xlink:href="pone.0016894.s002.doc"><caption><p><text><SENT sid="7118" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0016894.s003"><label>Table S1</label><caption><p><text><SENT sid="7119" pm="."><plain>List of 476 Differentially Expressed Transcripts Comparing Sod2-/- and Sod2+/+ Erythroblast Samples. Criteria used in filtering data were fold change ±1.5 with a corrected p value &lt;0.05 (Benjamini and Hochberg MTC used). </plain></SENT>
</text></p><p><text><SENT sid="7120" pm="."><plain>(DOC) </plain></SENT>
</text></p></caption><media xlink:href="pone.0016894.s003.doc"><caption><p><text><SENT sid="7121" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0016894.s004"><label>Table S2</label><caption><p><text><SENT sid="7122" pm="."><plain>KEGG Pathway Analysis of the 476 most highly differentially expressed genes. The GeneSifter program was used to generate a list of KEGG pathways using the 476 differentially expressed transcripts (fold change ±1.5 and corrected p &lt;0.05) from table S2 that differ between groups. </plain></SENT>
<SENT sid="7123" pm="."><plain>The top section of table shows results for all 476 differentially expressed transcripts, the middle panel shows analysis of only those transcripts that were expressed at higher levels in Sod2-/- cells, while the bottom panel shows only those transcripts that were expressed at lower levels in Sod2-/- cells. </plain></SENT>
<SENT sid="7124" pm="."><plain>In evaluating the significance of identified pathways, a Z score greater than 2 is considered significant. </plain></SENT>
<SENT sid="7125" pm="."><plain>However, the low number of identified genes in the set of transcripts with increased expression in Sod2-/- cells reduces confidence in some assignments. </plain></SENT>
<SENT sid="7126" pm="."><plain>The strongest assignments are to metabolic pathways, splicing, and DNA repair. </plain></SENT>
<SENT sid="7127" pm="."><plain>Several (strong) assignments are based upon overlapping gene sets (predominantly components of the oxidative phosphorylation pathway)—for instance Parkinson's and Huntington's Diseases, where a mitochondrial link to pathogenesis has been identified. </plain></SENT>
</text></p><p><text><SENT sid="7128" pm="."><plain>(DOC) </plain></SENT>
</text></p></caption><media xlink:href="pone.0016894.s004.doc"><caption><p><text><SENT sid="7129" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0016894.s005"><label>Table S3</label><caption><p><text><SENT sid="7130" pm="."><plain>KEGG Pathway Analysis of Entire Microarray Dataset. As in table S3 above, GeneSifter was used to identify affected KEGG pathways utilizing the entire microarray dataset (&gt;45,000 ‘genes’ on the Affymetrix mouse genome 430 2.0 array). </plain></SENT>
<SENT sid="7131" pm="."><plain>This provides a much broader view of altered metabolic, signal transduction and disease processes that share patterns of gene expression change with those seen in our comparison of Sod2+/+ versus Sod2-/- erythroblasts. </plain></SENT>
</text></p><p><text><SENT sid="7132" pm="."><plain>(DOC) </plain></SENT>
</text></p></caption><media xlink:href="pone.0016894.s005.doc"><caption><p><text><SENT sid="7133" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0016894.s006"><label>Table S4</label><caption><p><text><SENT sid="7134" pm="."><plain>Taqman Assays Used for qPCR Validation: Table S4 lists the endogenous control (18S), analyzed genes and the corresponding inventoried transcript-specific assays (Applied Biosystems Inc, Foster City, CA). </plain></SENT>
<SENT sid="7135" pm="."><plain>Assays were selected with the _m1 suffix; they are designed on exon/intron junctions and do not amplify genomic DNA. </plain></SENT>
</text></p><p><text><SENT sid="7136" pm="."><plain>(DOC) </plain></SENT>
</text></p></caption><media xlink:href="pone.0016894.s006.doc"><caption><p><text><SENT sid="7137" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="7138" pm="."><plain>We thank Daniel Salomon, Sunil Kurian, Ben Hock, Anastasia Kralli, Steven Head and the late Ernest Beutler for discussion and technical advice. </plain></SENT>
<SENT sid="7139" pm="."><plain>This is TSRI manuscript #18896-MEM. </plain></SENT>
</text></text4fund></p></ack></SecTag><fn-group><fn fn-type="COI-statement"><p><text><SENT sid="7140" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><SecTag type="ACK_FUND"><fn fn-type="financial-disclosure"><p><text4fund><text><SENT sid="7141" pm="."><plain>Funding: Sources of support for this work were NIH grants R21DK075063 and R01DK062473 from the NIDDK. </plain></SENT>
<SENT sid="7142" pm="."><plain>The website for the NIDDK is <ext-link ext-link-type="uri" xlink:href="http://www2.niddk.nih.gov/">http://www2.niddk.nih.gov/</ext-link>. </plain></SENT>
<SENT sid="7143" pm="."><plain>The funders had no role in study design, data collection and analysis, decision to publish or preparation of the this manuscript. </plain></SENT>
</text></text4fund></p></fn></SecTag></fn-group><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0016894-Friedman1"><text><SENT sid="7144" pm="."><plain>1 FriedmanJSRebelVIDerbyRBellKHuangTT 2001 Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med 193 925 934 11304553 </plain></SENT>
</text></ref><ref id="pone.0016894-Bottomley1"><text><SENT sid="7145" pm="."><plain>2 BottomleySS 2006 Congenital sideroblastic anemias. Curr Hematol Rep 5 41 49 16537045 </plain></SENT>
</text></ref><ref id="pone.0016894-Alcindor1"><text><SENT sid="7146" pm="."><plain>3 AlcindorTBridgesKR 2002 Sideroblastic anaemias. Br J Haematol 116 733 743 11886376 </plain></SENT>
</text></ref><ref id="pone.0016894-Fleming1"><text><SENT sid="7147" pm="."><plain>4 FlemingMD 2002 The genetics of inherited sideroblastic anemias. Semin Hematol 39 270 281 12382202 </plain></SENT>
</text></ref><ref id="pone.0016894-May1"><text><SENT sid="7148" pm="."><plain>5 MayAFitzsimonsE 1994 Sideroblastic anaemia. Baillieres Clin Haematol 7 851 879 7881157 </plain></SENT>
</text></ref><ref id="pone.0016894-Cotter1"><text><SENT sid="7149" pm="."><plain>6 CotterPDRucknagelDLBishopDF 1994 X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Blood 84 3915 3924 7949148 </plain></SENT>
</text></ref><ref id="pone.0016894-Allikmets1"><text><SENT sid="7150" pm="."><plain>7 AllikmetsRRaskindWHHutchinsonASchueckNDDeanM 1999 Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 8 743 749 10196363 </plain></SENT>
</text></ref><ref id="pone.0016894-Bykhovskaya1"><text><SENT sid="7151" pm="."><plain>8 BykhovskayaYCasasKMengeshaEInbalAFischel-GhodsianN 2004 Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74 1303 1308 15108122 </plain></SENT>
</text></ref><ref id="pone.0016894-Patton1"><text><SENT sid="7152" pm="."><plain>9 PattonJRBykhovskayaYMengeshaEBertolottoCFischel-GhodsianN 2005 Mitochondrial myopathy and sideroblastic anemia (MLASA): missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation. J Biol Chem 280 19823 19828 15772074 </plain></SENT>
</text></ref><ref id="pone.0016894-Bykhovskaya2"><text><SENT sid="7153" pm="."><plain>10 BykhovskayaYMengeshaEFischel-GhodsianN 2007 Pleiotropic effects and compensation mechanisms determine tissue specificity in mitochondrial myopathy and sideroblastic anemia (MLASA). Mol Genet Metab 91 148 156 17374500 </plain></SENT>
</text></ref><ref id="pone.0016894-Pearson1"><text><SENT sid="7154" pm="."><plain>11 PearsonHALobelJSKocoshisSANaimanJLWindmillerJ 1979 A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 95 976 984 501502 </plain></SENT>
</text></ref><ref id="pone.0016894-Camaschella1"><text><SENT sid="7155" pm="."><plain>12 CamaschellaCCampanellaADe FalcoLBoschettoLMerliniR 2007 The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 110 1353 1358 17485548 </plain></SENT>
</text></ref><ref id="pone.0016894-Guernsey1"><text><SENT sid="7156" pm="."><plain>13 GuernseyDLJiangHCampagnaDREvansSCFergusonM 2009 Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet 41 651 653 19412178 </plain></SENT>
</text></ref><ref id="pone.0016894-Bergmann1"><text><SENT sid="7157" pm="."><plain>14 BergmannAKCampagnaDRMcLoughlinEMAgarwalSFlemingMD 2009 Systematic molecular genetic analysis of congenital sideroblastic anemia: Evidence for genetic heterogeneity and identification of novel mutations. Pediatr Blood Cancer  </plain></SENT>
</text></ref><ref id="pone.0016894-Gattermann1"><text><SENT sid="7158" pm="."><plain>15 GattermannNRetzlaffSWangYLHofhausGHeinischJ 1997 Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood 90 4961 4972 9389715 </plain></SENT>
</text></ref><ref id="pone.0016894-Gattermann2"><text><SENT sid="7159" pm="."><plain>16 GattermannNWulfertMJungeBGermingUHaasR 2004 Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome. Blood 103 1499 1502 14576046 </plain></SENT>
</text></ref><ref id="pone.0016894-Gattermann3"><text><SENT sid="7160" pm="."><plain>17 GattermannN 2000 From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. Leuk Res 24 141 151 10654450 </plain></SENT>
</text></ref><ref id="pone.0016894-Gattermann4"><text><SENT sid="7161" pm="."><plain>18 GattermannNRetzlaffSWangYLBerneburgMHeinischJ 1996 A heteroplasmic point mutation of mitochondrial tRNALeu(CUN) in non- lymphoid haemopoietic cell lineages from a patient with acquired idiopathic sideroblastic anaemia. Br J Haematol 93 845 855 8703816 </plain></SENT>
</text></ref><ref id="pone.0016894-Wang1"><text><SENT sid="7162" pm="."><plain>19 WangYLChoiHKAulCGattermannNHeinischJ 1999 The MERRF mutation of mitochondrial DNA in the bone marrow of a patient with acquired idiopathic sideroblastic anemia. Am J Hematol 60 83 84 9883816 </plain></SENT>
</text></ref><ref id="pone.0016894-Shin1"><text><SENT sid="7163" pm="."><plain>20 ShinMGKajigayaSLevinBCYoungNS 2003 Mitochondrial DNA mutations in patients with myelodysplastic syndromes. Blood 101 3118 3125 12446454 </plain></SENT>
</text></ref><ref id="pone.0016894-Beck1"><text><SENT sid="7164" pm="."><plain>21 BeckEAZieglerGSchmidRLudinH 1967 Reversible sideroblastic anemia caused by chloramphenicol. Acta Haematol 38 1 10 4963348 </plain></SENT>
</text></ref><ref id="pone.0016894-Sharp1"><text><SENT sid="7165" pm="."><plain>22 SharpRALoweJGJohnstonRN 1990 Anti-tuberculous drugs and sideroblastic anaemia. Br J Clin Pract 44 706 707 2102203 </plain></SENT>
</text></ref><ref id="pone.0016894-Yunis1"><text><SENT sid="7166" pm="."><plain>23 YunisAASalemZ 1980 Drug-induced mitochondrial damage and sideroblastic change. Clin Haematol 9 607 619 7004688 </plain></SENT>
</text></ref><ref id="pone.0016894-Li1"><text><SENT sid="7167" pm="."><plain>24 LiYHuangTTCarlsonEJMelovSUrsellPC 1995 Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11 376 381 7493016 </plain></SENT>
</text></ref><ref id="pone.0016894-Friedman2"><text><SENT sid="7168" pm="."><plain>25 FriedmanJSLopezMFFlemingMDRiveraAMartinFM 2004 SOD2 Deficiency Anemia: Protein Oxidation and Altered Protein Expression Reveal Targets of Damage, Stress Response and Anti-oxidant Responsiveness. Blood 104 2565 2573 15205258 </plain></SENT>
</text></ref><ref id="pone.0016894-Martin1"><text><SENT sid="7169" pm="."><plain>26 MartinFMBydlonGWelshMLFriedmanJS 2005 A method for rapid mouse siderocyte enrichment. Exp Hematol 33 1493 1499 16338492 </plain></SENT>
</text></ref><ref id="pone.0016894-Martin2"><text><SENT sid="7170" pm="."><plain>27 MartinFMBydlonGFriedmanJS 2006 SOD2-deficiency sideroblastic anemia and red blood cell oxidative stress. Antioxid Redox Signal 8 1217 1225 16910769 </plain></SENT>
</text></ref><ref id="pone.0016894-Martin3"><text><SENT sid="7171" pm="."><plain>28 MartinFMPrchalJNievaJSavenAAndreyJ 2008 Purification and Characterization of Sideroblasts from Patients with Acquired and Hereditary Sideroblastic Anemia. British Journal of Haematology in press  </plain></SENT>
</text></ref><ref id="pone.0016894-Socolovsky1"><text><SENT sid="7172" pm="."><plain>29 SocolovskyMNamHFlemingMDHaaseVHBrugnaraC 2001 Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98 3261 3273 11719363 </plain></SENT>
</text></ref><ref id="pone.0016894-Zhang1"><text><SENT sid="7173" pm="."><plain>30 ZhangJSocolovskyMGrossAWLodishHF 2003 Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 102 3938 3946 12907435 </plain></SENT>
</text></ref><ref id="pone.0016894-Ashburner1"><text><SENT sid="7174" pm="."><plain>31 AshburnerMBallCABlakeJABotsteinDButlerH 2000 Gene ontology: tool for the unification of biology. </plain></SENT>
<SENT sid="7175" pm="."><plain>The Gene Ontology Consortium. Nat Genet 25 25 29 10802651 </plain></SENT>
</text></ref><ref id="pone.0016894-Doniger1"><text><SENT sid="7176" pm="."><plain>32 DonigerSWSalomonisNDahlquistKDVranizanKLawlorSC 2003 MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4 R7 12540299 </plain></SENT>
</text></ref><ref id="pone.0016894-Melov1"><text><SENT sid="7177" pm="."><plain>33 MelovSCoskunPPatelMTuinstraRCottrellB 1999 Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A 96 846 851 9927656 </plain></SENT>
</text></ref><ref id="pone.0016894-Burgess1"><text><SENT sid="7178" pm="."><plain>34 BurgessSCHeTYanZLindnerJSherryAD 2007 Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab 5 313 320 17403375 </plain></SENT>
</text></ref><ref id="pone.0016894-Wallace1"><text><SENT sid="7179" pm="."><plain>35 WallaceDC 1999 Mitochondrial diseases in man and mouse. Science 283 1482 1488 10066162 </plain></SENT>
</text></ref><ref id="pone.0016894-Wallace2"><text><SENT sid="7180" pm="."><plain>36 WallaceDC 2001 A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found Symp 235 247 263; discussion 263-246 11280029 </plain></SENT>
</text></ref><ref id="pone.0016894-Andersson1"><text><SENT sid="7181" pm="."><plain>37 AnderssonUScarpullaRC 2001 Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol Cell Biol 21 3738 3749 11340167 </plain></SENT>
</text></ref><ref id="pone.0016894-Scarpulla1"><text><SENT sid="7182" pm="."><plain>38 ScarpullaRC 2008 Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 88 611 638 18391175 </plain></SENT>
</text></ref><ref id="pone.0016894-Spiegelman1"><text><SENT sid="7183" pm="."><plain>39 SpiegelmanBM 2007 Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found Symp 287 60 63; discussion 63-69 18074631 </plain></SENT>
</text></ref><ref id="pone.0016894-Sankaran1"><text><SENT sid="7184" pm="."><plain>40 SankaranVGOrkinSHWalkleyCR 2008 Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev 22 463 475 18258751 </plain></SENT>
</text></ref><ref id="pone.0016894-Larsson1"><text><SENT sid="7185" pm="."><plain>41 LarssonNGWangJWilhelmssonHOldforsARustinP 1998 Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18 231 236 9500544 </plain></SENT>
</text></ref><ref id="pone.0016894-Klausner1"><text><SENT sid="7186" pm="."><plain>42 KlausnerRDRouaultTAHarfordJB 1993 Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72 19 28 8380757 </plain></SENT>
</text></ref><ref id="pone.0016894-Rouault1"><text><SENT sid="7187" pm="."><plain>43 RouaultTA 2006 The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2 406 414 16850017 </plain></SENT>
</text></ref><ref id="pone.0016894-Hentze1"><text><SENT sid="7188" pm="."><plain>44 HentzeMWRouaultTACaughmanSWDancisAHarfordJB 1987 A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron. Proc Natl Acad Sci U S A 84 6730 6734 3477805 </plain></SENT>
</text></ref><ref id="pone.0016894-Boultwood1"><text><SENT sid="7189" pm="."><plain>45 BoultwoodJPellagattiANikpourMPushkaranBFidlerC 2008 The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS ONE 3 e1970 18398482 </plain></SENT>
</text></ref><ref id="pone.0016894-Srinivasan1"><text><SENT sid="7190" pm="."><plain>46 SrinivasanVNetzDJWebertHMascarenhasJPierikAJ 2007 Structure of the yeast WD40 domain protein Cia1, a component acting late in iron-sulfur protein biogenesis. Structure 15 1246 1257 17937914 </plain></SENT>
</text></ref><ref id="pone.0016894-Balk1"><text><SENT sid="7191" pm="."><plain>47 BalkJAguilar NetzDJTepperKPierikAJLillR 2005 The essential WD40 protein Cia1 is involved in a late step of cytosolic and nuclear iron-sulfur protein assembly. Mol Cell Biol 25 10833 10841 16314508 </plain></SENT>
</text></ref><ref id="pone.0016894-Lockhart1"><text><SENT sid="7192" pm="."><plain>48 LockhartDJDongHByrneMCFollettieMTGalloMV 1996 Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14 1675 1680 9634850 </plain></SENT>
</text></ref><ref id="pone.0016894-Benjamini1"><text><SENT sid="7193" pm="."><plain>49 BenjaminiYHochbergY 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57 289 300  </plain></SENT>
</text></ref><ref id="pone.0016894-Hochberg1"><text><SENT sid="7194" pm="."><plain>50 HochbergYBenjaminiY 1990 More powerful procedures for multiple significance testing. Stat Med 9 811 818 2218183 </plain></SENT>
</text></ref><ref id="pone.0016894-Livak1"><text><SENT sid="7195" pm="."><plain>51 LivakKJSchmittgenTD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 402 408 11846609 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
